InvestorsHub Logo
Followers 276
Posts 32697
Boards Moderated 0
Alias Born 11/14/2013

Re: None

Wednesday, 03/27/2024 11:41:16 AM

Wednesday, March 27, 2024 11:41:16 AM

Post# of 699226
Question. Now that we have two patents for DCVax-Direct in India that go out to 2036, and knowing that India already allows Intratumoral dendritic therapy (albeit an arguably substantially inferior product), while also knowing DCVax-Direct is incredibly safe, and knowing DCVax-Direct had a strong phase 1 survival record in treating inoperable tumors, and knowing these patents are for treating inoperable advanced cancers, plus understanding these people are in emergency situations, while also understanding most of the world would be obliged to using real world data studies, is it possible there is an accelerated pathway for DCVax-Direct in India?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News